ROCHE HOLDING AG INHABER-GENUSSS
ROCHE HOLDING AG INHABER-GENUSSS/ CH0012032048 /
855167
18.10.2024 13:06:01
|
Изменение
+1.600
|
Объем сделки |
Бид13:06:01 |
Предложение13:06:01 |
Рыночная капитализация |
Дивидендная доходность |
Коэффициент Цена/Доход |
289.200EUR
|
+0.56%
|
- Оборот: - |
289.200Величина цены спроса: - |
290.200Величина цены предложения: - |
269.09 млрдEUR |
- |
- |
Описание деятельности
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
Правление & Наблюдательный совет
Исполнительный директор |
Dr. Thomas Schinecker |
Правление |
Dr. Alan Hippe, Cristina A. Wilbur, Teresa Graham, Matt Sause , Claudia Bockstiegel, Prof. Dr. Hans Clevers, Dr. Levi Garraway, Silke Hornstein, Dr. Aviv Regev, Barbara Schädler, Boris L. Zaïtra |
Наблюдательный совет |
Dr. Severin Schwan, André Hoffmann, Anita Hauser, Dr. Claudia Süssmuth Dyckerhoff, Dr. Patrick Frost, Prof. Dr. Richard Lifton, Dr. Mark Schneider, Dr. Jemilah Mahmood, Prof. Dr. Akiko Iwasaki, Dr. Jörg Duschmalé |
Данные компании
Имя: |
Roche Holding |
Адрес: |
Grenzacherstraße 124,CH-4070 Basel |
Телефон: |
+41-61-688-1111 |
Факс: |
- |
E-mail: |
basel.webmaster@roche.com
|
Интернет: |
www.roche.com |
Индустрия: |
Healthcare |
Сектор: |
Pharmaceutical Industry |
Подсектор: |
Pharmaceuticals |
Конец финансового года: |
31.12 |
Акции в свободном обращении: |
88.00% |
Дата IPO: |
03.04.1995 |
Связи с инвесторами
Имя: |
Bruno Eschli |
IR телефон: |
+41 (61) 687 5284 |
IR-факс: |
+41 (61) 691 0014 |
IR e-mail: |
bruno.eschli@roche.com
|
Календарь компании
CW 43 | 23.10.2024
Interim Report 3rd Quarter/9 Months
|
CW 5 | 30.01.2025
4th Quarter/Annual Report
|